Your browser doesn't support javascript.
loading
Prognostic value of SPECT myocardial perfusion entropy in high-risk type 2 diabetic patients.
Djaileb, Loïc; Seiller, Alexandre; Canu, Marjorie; De Leiris, Nicolas; Martin, Alix; Poujol, Julie; Fraguas-Rubio, Alicia; Leenhardt, Julien; Carabelli, Adrien; Calizzano, Alex; De Fondaumière, Marie; Broisat, Alexis; Desvignes, Michel; Vanzetto, Gérald; Ghezzi, Catherine; Fagret, Daniel; Riou, Laurent M; Barone-Rochette, Gilles.
Afiliación
  • Djaileb L; Nuclear Medicine Department, Grenoble-Alpes University Hospital, Grenoble, France. LDjaileb@chu-grenoble.fr.
  • Seiller A; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France. LDjaileb@chu-grenoble.fr.
  • Canu M; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France.
  • De Leiris N; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France.
  • Martin A; Cardiology Department, Grenoble-Alpes University Hospital, Grenoble, France.
  • Poujol J; Nuclear Medicine Department, Grenoble-Alpes University Hospital, Grenoble, France.
  • Fraguas-Rubio A; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France.
  • Leenhardt J; Cardiology Department, Clinique Mutualiste, Grenoble, France.
  • Carabelli A; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France.
  • Calizzano A; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France.
  • De Fondaumière M; Nuclear Medicine Department, Grenoble-Alpes University Hospital, Grenoble, France.
  • Broisat A; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France.
  • Desvignes M; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France.
  • Vanzetto G; Cardiology Department, Grenoble-Alpes University Hospital, Grenoble, France.
  • Ghezzi C; Nuclear Medicine Department, Grenoble-Alpes University Hospital, Grenoble, France.
  • Fagret D; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France.
  • Riou LM; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France.
  • Barone-Rochette G; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France.
Eur J Nucl Med Mol Imaging ; 48(6): 1813-1821, 2021 06.
Article en En | MEDLINE | ID: mdl-33219463
ABSTRACT

PURPOSE:

Risk stratification of patients with type 2 diabetes mellitus (T2D) remains suboptimal. We hypothesized that myocardial perfusion entropy (MPE) quantified from SPECT myocardial perfusion images may provide incremental prognostic value in T2D patients independently from myocardial ischemia.

METHODS:

T2D patients with very high and high cardiovascular risk were prospectively included (n = 166, 65 ± 12 years). Stress perfusion defect was quantified by visual evaluation of SPECT MPI. SPECT MPI was also used for the quantification of rest and stress MPE. The primary end point was major adverse cardiac events (MACEs) defined as cardiac death, myocardial infarction (MI), and myocardial revascularization > 3 months after SPECT.

RESULTS:

Forty-four MACEs were observed during a 4.6-year median follow-up. Significant differences in stress MPE were observed between patients with and without MACEs (4.19 ± 0.46 vs. 3.93 ± 0.40; P ≤ .01). By Kaplan-Meier analysis, the risk of MACEs was significantly higher in patients with higher stress MPE (log-rank P ≤ 01). Stress MPE and stress perfusion defect (SSS ≥ 4) were significantly associated with the risk of MACEs (hazard ratio 2.77 and 2.06, respectively, P < .05 for both) after adjustment for clinical and imaging risk predictors as identified from preliminary univariate analysis. MPE demonstrated incremental prognostic value over clinical risk factors, stress test EKG and SSS as evidenced by nested models showing improved Akaike information criterion (AIC), reclassification (global continuous net reclassification improvement [NRI] 63), global integrated discrimination improvement (IDI 6%), and discrimination (change in c-statistic 0.66 vs 0.74).

CONCLUSIONS:

Stress MPE provided independent and incremental prognostic information for the prediction of MACEs in diabetic patients. TRIAL REGISTRATION NUMBER NCT02316054 (12/12/2014).
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Diabetes Mellitus Tipo 2 / Imagen de Perfusión Miocárdica Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2021 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Diabetes Mellitus Tipo 2 / Imagen de Perfusión Miocárdica Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2021 Tipo del documento: Article País de afiliación: Francia